Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$143,399
+$38,197 QoQ
Shares Held
396
+32.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,910
of 3,155 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026S&T Bank/PA holds $6,307,683 across 11 Drug Manufacturers - General names. AMGN ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
18,356 | $4,619,103 | |
| 2 | JNJ |
Johnson & Johnson
|
2,265 | $575,242 | |
| 3 | LLY |
ELI LILLY & Co
|
302 | $362,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,829 | $235,026 | |
| 5 | AMGN |
Amgen Inc
This page
|
396 | $143,399 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,458 | $141,629 | |
| 7 | PFE |
Pfizer Inc
|
5,442 | $131,042 | |
| 8 | NVO |
Novo Nordisk A S
|
1,300 | $62,322 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,399 | 396 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $105,202 | 299 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $97,210 | 297 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $51,924 | 184 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $51,374 | 184 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $55,766 | 179 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $45,611 | 175 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||